Last week, Argentina and Mexico announced they will produce the coronavirus vaccine jointly developed by Oxford University and pharmaceutical company AstraZeneca.

And on Friday, Argentina announced it will run a phase 3 trial with one of the vaccines developed by China. 

Progress toward a licensed COVID-19 vaccine is some much needed positive news in Latin America—which now has the highest number of cases and deaths in the world.

Check out The China Report, our new weekly newsletter. Subscribe here!